Projects per year
Abstract
Pharmacological evidence suggests the importance of noradrenergic and other monoaminergic neurotransmitters in the aetiology and treatment of attention deficit hyperactivity disorder (ADHD). Until recently, the genes of the noradrenergic pathway were not intensively investigated in ADHD compared to dopaminergic and serotonergic candidates
Original language | English |
---|---|
Pages (from-to) | 895 - 902 |
Number of pages | 8 |
Journal | Psychopharmacology |
Volume | 225 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2013 |
Projects
- 1 Finished
-
Functional characterisation of genetic risk variants for ADHD: from Association to Biology
Hawi, Z. (Primary Chief Investigator (PCI)), Bellgrove, M. (Chief Investigator (CI)), Vance, A. L. A. (Chief Investigator (CI)) & Wallace, R. H. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/11 → 31/12/13
Project: Research